Antibody Therapeutics
Q2 Journal
Open Access
Journal
Country
United States
Northern America
Subject Area and Category
Immunology and Microbiology
└
Immunology
Q2
└
Immunology and Allergy
Q2
Publisher
SJR 2025
1.003
Q2
SJR Score
H-Index
30
Citations / Doc (2yr)
4.17
Total Docs. (latest)
26
Total Citations (3yr)
405
Publication type
Journals
ISSN
25164236
Coverage
2018-2026
Journal Rank
#4,893
Subject Categories
Immunology
Q2
Immunology and Allergy
Q2
Subject Areas
Aims & Scope
A peer-reviewed, online, open access journal, Antibody Therapeutics provides a forum for the publication of the latest advances and challenges in the discovery, research, development, manufacturing, and methodology of therapeutic antibodies for the global scientific community.
Topics include target and antibody discovery, mechanistic research, new technologies and methods, manufacturing, clinical trials, regulation, policies, and more.
Antibody Therapeutics article types include original research, reviews, cutting-edge technologies, new methods, news, interviews, and meeting highlights.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Embase
Detailed Metrics
| Total Docs. (latest) | 26 |
| Total Docs. (3 years) | 88 |
| Total Refs. | 2,191 |
| Total Citations (3 years) | 405 |
| Citable Docs. (3 years) | 88 |
| Citations / Doc. (2 years) | 4.17 |
| Ref. / Doc. | 84.27 |
| % Female | 42.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.